Biotin deficiencies lead to dysbiosis of the gut and a reduction in mucus-resident microbes, leading to characteristics of Inflammatory Bowel Disease (IBD), according to a new study in mice.
Biosyntia’s efforts to commercialise a bio-based form of vitamin B7 appear on track after the Danish-based biotech firm closes a €11.5m Series B funding round.
Danish biotech company, Biosyntia, and Munich-based, Wacker Group, are planning to expand production of fermentation-based biotin across Europe and into new markets.
China accounts for about 80% of the global biotin supply, making it the largest biotin production country in the world. While supply chain dependency on China is a well-known fact for the United States, the crippling impact of the coronavirus in recent...